Physician profile
John H Williams
NPI 1720076573
$1,320.65
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $78.00 · 2022: $445 · 2023: $264 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $390.00 | 2019-2023 | Lo Loestrin Fe |
| Intuitive Surgical, INC. | $157.99 | 2024 | |
| Mayne Pharma Commercial LLC | $120.57 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $110.47 | 2023 | Myfembree |
| Avion Pharmaceuticals | $90.73 | 2019-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $89.73 | 2019-2023 | |
| Lupin INC. | $46.15 | 2019-2020 | |
| Pfizer INC. | $44.88 | 2022 | |
| Ascend Therapeutics US, LLC | $36.05 | 2019 | |
| Therapeuticsmd, INC. | $35.88 | 2019-2020 | |
| Evofem Biosciences, INC. | $34.28 | 2022 | |
| Mission Pharmacal Company | $29.46 | 2019 | |
| Smith+Nephew, INC. | $21.82 | 2022 | |
| Mylan Pharmaceuticals INC. | $20.65 | 2022 | |
| Organon LLC | $17.27 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $17.10 | 2022 | |
| Exeltis, USA INC. | $15.58 | 2023 | Slynd |
| Amag Pharmaceuticals, INC. | $14.84 | 2019 | |
| Duchesnay USA Incorporated | $14.49 | 2019 | |
| Coopersurgical, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.